B K Link - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

B K Link

Showing results (1-10 of 26) with videos related to

Pageof 3

Sort By:

Clinical Pharmacology and Therapeutics|September 20, 2008

Imaging guiding therapy development in lymphomaB K Link

Blood|June 15, 1993

Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cellsB K Link, G J Weiner

Leukemia & Lymphoma|December 30, 1998

Monoclonal antibodies in the treatment of human B-cell malignanciesB K Link, G J Weiner

Transplantation Proceedings|December 29, 2004

Follicular lymphoma following liver transplantation: report of a unique case with review of the literatureM M Racz, B K Link, M A Vasef

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001

Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancerG M Buban, B K Link, W R Doucette

Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2015

Isolated unilateral facial nerve palsy: an unusual manifestation of recurrent diffuse large B-cell lymphomaR L Naridze, J C Selby, B K Link, et al.

Clinical Lymphoma|January 10, 2002

Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphomaK S Brown, D J Levitt, M Shannon, et al.

Leukemia & Lymphoma|October 21, 2005

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.

Leukemia|March 11, 2005

Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicityB Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.

International Journal of Cancer|July 3, 1998

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanismsB K Link, S A Kostelny, M S Cole, et al.

Pageof 3

Search research articles

Showing results (1-10 of 26) with videos related to

Sort By:

Pageof 3

Clinical Pharmacology and Therapeutics|September 20, 2008

Imaging guiding therapy development in lymphomaB K Link

Blood|June 15, 1993

Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cellsB K Link, G J Weiner

Leukemia & Lymphoma|December 30, 1998

Monoclonal antibodies in the treatment of human B-cell malignanciesB K Link, G J Weiner

Transplantation Proceedings|December 29, 2004

Follicular lymphoma following liver transplantation: report of a unique case with review of the literatureM M Racz, B K Link, M A Vasef

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001

Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancerG M Buban, B K Link, W R Doucette

Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2015

Isolated unilateral facial nerve palsy: an unusual manifestation of recurrent diffuse large B-cell lymphomaR L Naridze, J C Selby, B K Link, et al.

Clinical Lymphoma|January 10, 2002

Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphomaK S Brown, D J Levitt, M Shannon, et al.

Leukemia & Lymphoma|October 21, 2005

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.

Leukemia|March 11, 2005

Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicityB Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.

International Journal of Cancer|July 3, 1998

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanismsB K Link, S A Kostelny, M S Cole, et al.

Pageof 3